Where to buy Amivantamab

Amivantamab (Amivantamab) is a biologic drug used to treat certain patients with non-small cell lung cancer (NSCLC), especially those with specific genetic mutations. Evantuzumab is not currently available in China, so patients cannot purchase it domestically and need to purchase evantuzumab through foreign channels. The main indication of evantumumab is the treatment of EGFR Exon 20 Insertion Mutation-positive advanced NSCLC. This specific mutation is rare in NSCLC, but it is often insensitive to traditional EGFR inhibitor drugs, so treating these patients has been a challenge. The emergence of evantumumab fills this gap in treatment needs and provides patients with new treatment options.